[Lyell's syndrome in adults. Prognostic elements and therapeutic deductions. Study of 27 cases].
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001463:Barbiturates / Q000009:adverse effects; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D008875:Middle Aged; D011379:Prognosis; D011720:Pyrazoles / Q000009:adverse effects; D012769:Shock / Q000209:etiology; D012772:Shock, Septic / Q000209:etiology; D013262:Stevens-Johnson Syndrome / Q000139:chemically induced* / Q000150:complications / Q000188:drug therapy; D013449:Sulfonamides / Q000009:adverse effects
D000305:Adrenal Cortex Hormones; D000900:Anti-Bacterial Agents; D001463:Barbiturates; D011720:Pyrazoles; D013449:Sulfonamides
Syndrome de Lyell de l'adulte. Eléments de pronostic et déductions thérapeutiques. Etude de 27 cas